연구성과로 돌아가기
2025 연구성과별 연구자 정보 (320 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Yan, Lunan | Yan, LA | 20 | Sichuan Univ, Liver Transplantat Ctr, Dept Liver Surg, West China Hosp, Chengdu, Peoples R China | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Chiu, Chang-Fang | Chiu, CF | 21 | China Med Univ Hosp, Canc Ctr, Dept Internal Med, Taichung, Taiwan | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Chiu, Chang-Fang | Chiu, CF | 21 | China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Santos, Florinda A. | Santos, FA | 22 | Barretos Canc Hosp, Dept Oncol, Barretos, Brazil | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Veluvolu, Anil | Veluvolu, A | 23 | Willis Knighton Med Ctr, Willis Knighton Hematol Oncol, Shreveport, LA USA | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Thungappa, Satheesh Chiradoni | Thungappa, SC | 24 | HCG Oncol, Dept Med Oncol, Bangalore, India | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Matos, Marco | Matos, M | 25 | Pindara Private Hosp, Oncol, Benowa, Qld, Australia | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Zotkiewicz, Magdalena | Zotkiewicz, M | 26 | AstraZeneca, Oncol Biometr, Late Oncol Stat, Warsaw, Poland | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Udoye, Stephanie, I | Udoye, S | 27 | AstraZeneca, Global Med Dev, Gaithersburg, MD USA | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Kurland, John F. | Kurland, JF | 28 | AstraZeneca, Global Med Dev, Gaithersburg, MD USA | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Cohen, Gordon J. | Cohen, GJ | 29 | AstraZeneca, Global Med Dev, Gaithersburg, MD USA | bsangro@unav.es; | |||||
| Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study | Lencioni, Riccardo | Lencioni, R | 30 | Univ Pisa, Med Sch, Pisa, Italy | bsangro@unav.es; | |||||
| Dynamic Adaptive Event-Triggered Mechanism for Fractional-Order Nonlinear Multi-Agent Systems with Actuator Saturation and External Disturbances: Application to Synchronous Generators | Narayanan, G. | Narayanan, G | 1 | Kyungpook Natl Univ, Sch Elect & Elect Engn, Daegu 41566, South Korea | narayananknu@knu.ac.kr; baskarm.ccm@citchennai.net; gokulakrishnanv@citchennai.net; stahn@knu.ac.kr; | |||||
| Dynamic Adaptive Event-Triggered Mechanism for Fractional-Order Nonlinear Multi-Agent Systems with Actuator Saturation and External Disturbances: Application to Synchronous Generators | Baskar, M. | Baskar, M | 2 | Chennai Inst Technol, Ctr Computat Modeling, Chennai 600009, Tamil Nadu, India | narayananknu@knu.ac.kr; baskarm.ccm@citchennai.net; gokulakrishnanv@citchennai.net; stahn@knu.ac.kr; | |||||
| Dynamic Adaptive Event-Triggered Mechanism for Fractional-Order Nonlinear Multi-Agent Systems with Actuator Saturation and External Disturbances: Application to Synchronous Generators | Gokulakrishnan, V. | Gokulakrishnan, V | 3 | Chennai Inst Technol, Ctr Computat Modeling, Chennai 600009, Tamil Nadu, India | narayananknu@knu.ac.kr; baskarm.ccm@citchennai.net; gokulakrishnanv@citchennai.net; stahn@knu.ac.kr; |
페이지 이동: